Press Releases
-
PHARMASEAL Launches Second Major Release of Engility CTMS
NOTTINGHAM, UNITED KINGDOM - Jul 8, 2019 - PHARMASEAL, a new provider of clinical trial management and governance solutions to enter the market, announces a second major release of its Engility CTMS platform
Jul 8, 2019
-
Certara Announces First Recipients of Certara-Monash University Industry Drug Development Fellowships
PRINCETON, NJ - Jun 25, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, and Monash University today announced the recipients of the inaugural Certara-Monash University Industry Drug Development Fellowships – Dr
Jun 25, 2019
-
ERT Participates in Groundbreaking, Digital Technology Research
PHILADELPHIA, PA, UNITED STATES - Jun 24, 2019 - ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced its involvement in a groundbreaking project to enhance drug development and improve the clinical management of mobility loss
Jun 24, 2019
-
ERT Showcases Scientific and Technological Expertise in Improving Clinical Research at DIA Annual Meeting
PHILADELPHIA, PA, UNITED STATES - Jun 20, 2019 - ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced its scientific and technological experts will present a series of innovative and educational live sessions and posters at the 2019 Drug Information Association (DIA) Annual Meeting in San Diego, June 23-27
Jun 20, 2019
-
IDDI IN COLLABORATION WITH ROCHE HAVE IDENTIFIED WHY USING DISEASE FREE SURVIVAL AS A PRIMARY ENDPOINT IN EARLY BREAST CANCER IS THE WAY FORWARD
LOUVAIN-LA-NEUVE, BELGIUM - Jun 20, 2019 - IDDIs findings suggest that it is appropriate to use disease-free survival (DFS) as a surrogate for overall survival (OS) in trials in HER-2-positive, early breast cancer
Jun 20, 2019
-
Shimmer and ClearSky Announce Partnership to Improve Analysis of Wearable Sensor Data for CNS Diseases
CAMBRIDGE, MA - Jun 19, 2019 - Shimmer Research, a global leader in wearable technology for research applications, and ClearSky Medical Diagnostics, a leader in analyzing wearable data for medical applications, today announced they are partnering to bring a new level of analytic capabilities to the use of wearable sensors in clinical research
Jun 19, 2019
-
Signant Health Experts Share Benefit of Integrating Patient-Centric Technology Solutions at Global Life Sciences Annual Forum DIA 2019
PHILADELPHIA, PA, UNITED STATES - Jun 18, 2019 - Signant Health (formerly CRF Health and Bracket) will provide expert insights at the forthcoming DIA Global Annual Meeting in San Diego, CA
Jun 18, 2019
-
Parexel Strengthens Risk-Based Monitoring Offering with CluePoints’ New Advanced Statistical Capabilities
WAYNE, PA - Jun 18, 2019 - Parexel, a leading provider of Clinical, Consulting and Commercial solutions to accelerate the development of innovative new therapies to improve the worlds health, today announced its strategic collaboration with CluePoints, an industry-leading provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software, to enhance overall data quality oversight and ensure regulatory compliance within clinical trials
Jun 18, 2019
-
Rho Facilitates Conversation on Change and Collaboration at DIA 2019
DURHAM, NC - Jun 14, 2019 - Rho Facilitates Conversation on Change and Collaboration at DIA 2019Experts fromCRO to share best practices and lessons learned on Change Management andEffective Stakeholder Collaboration WHAT: Rho, a full-service contract research organization (CRO), will highlight its clinical trial expertise during the Drug Information Association (DIA) Annual Meeting, being held June 23-27 in San Francisco
Jun 13, 2019
-
Signant Health Appoints Lawrence Miller as Chief Technology Officer
PLYMOUTH MEETING, PA - Jun 13, 2019 - Signant Health, formerly CRF Bracket, has appointed Lawrence Miller as Chief Technology Officer. Signant unites electronic Clinical Outcomes Assessment (eCOA), eConsent, Patient Engagement, Interactive Response Technology (IRT), Clinical Supply Management and Endpoint Quality into the industrys most comprehensive patient-centric suite of technology solutions and services
Jun 13, 2019
-
Certara’s Simcyp PBPK Modeling and Simulation Technology Achieves First FDA Virtual Bioequivalence Approval for ‘Complex’ Generic Drug
PRINCETON, NJ - Jun 12, 2019 - Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that its Simcyp® physiologically-based pharmacokinetic (PBPK) modeling and simulation technology was used to demonstrate bioequivalence (BE) for the US Food and Drug Administration (FDA) approval of a complex generic drug on the agencys abbreviated new drug application (ANDA) pathway
Jun 12, 2019
-
Amsterdam University Medical Center wins MR Solutions’ newly launched Image of the Year Award
GUILDFORD, UNITED KINGDOM - Jun 11, 2019 - The Amsterdam University Medical Center has won MR Solutions Image of the Year 2019 award for the best molecular research image
Jun 11, 2019
-
ERT Enhances its Adaptive eC-SSRS for More Effective Suicide Risk Assessment
PHILADELPHIA, PA, UNITED STATES - Jun 11, 2019 - ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced advancements to its unique electronic Columbia-Suicide Severity Rating Scale (eC-SSRS), an electronic, self-rated patient reported outcome assessment conducted at investigative sites to assess treatment-emergent suicidal ideation and behavior (SIB) during clinical trials
Jun 11, 2019
-
Quanticate Expands Presence in North America with New Toronto Office
TORNTO, ON, CANADA - Jun 11, 2019 - Quanticate, a leading global data-focused clinical research organisation (CRO), has announced plans to expand its presence in North America with the opening of a new office in Toronto
Jun 10, 2019
-
Certara Scientists to Highlight Model-informed Drug Development, PBPK, MBMA and Quantitative Systems Pharmacology Progress at PAGE 2019
PRINCETON, NJ - Jun 10, 2019 - Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that its scientists will participate in 28 sessions at the Population Approach Group in Europe (PAGE) 2019 Annual Meeting
Jun 10, 2019
-
Rho Experts Discuss the Importance of Early Patient Involvement in Clinical Trial Design in Free Webinar
DURHAM, NC - Jun 6, 2019 - Rho Experts Discuss the Importance of Early Patient Involvement inClinical Trial Design in Free Webinar WHAT: Patient-centricity gets a lot of buzz as an essential aspect in research, drug development and disease management
Jun 5, 2019
-
BioIVT HEPATOPAC® Meeting to Highlight Advances in Drug Discovery Research
WESTBURY, NY - Jun 3, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will be hosting a HEPATOPAC Meeting at the AC Hotel by Marriott, San Francisco Airport/Oyster Point Waterfront on June 7
Jun 3, 2019
-
MR Solutions’ multi-modality, cryogen free technology is recognised as the norm at the ISMRM meeting in Montreal
GUILDFORD, UNITED KINGDOM - May 30, 2019 - PRESS RELEASE24.05.19 MR Solutions high field simultaneous PET-MR systems and large bore, 7T cryogen free MRI technology were seen to be game-changers by leading molecular imaging researchers at the 27th Annual Meeting of the International Society for Magnetic Resonance in Medicine (ISMRM)[i], in Montreal last week
May 30, 2019
-
CRF Bracket’s World-Class Clinical Research Technology wins European PIN Award for Second Year in Row
PHILADELPHIA, PA - May 30, 2019 - CRF Brackets Romania office celebrates yet another European award after being named IT Company of the Year in Romanias Regional IT & Outsourcing Industry Awards (also known as the PIN Awards)
May 30, 2019
-
BioIVT Named Service Provider for Promega Immunotherapy Bioassays
WESTBURY, NY - May 29, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will now offer Promega Immune Checkpoint and antibody-dependent cell-mediated cytotoxicity (ADCC) Reporter Bioassays to support immunology and immuno-oncology research
May 29, 2019
